Recovery of mouse neuromuscular junctions from single and repeated injections of botulinum neurotoxin A

Journal of Physiology

Volumn 586, Issue 13, 2008, Pages 3163-3182

  Rogozhin, A A ^a   Pang, K K ^b   Bukharaeva, E ^c   Young, C ^b   Slater, C R ^b  

^a KAZAN STATE MEDICAL ACADEMY   (Russian Federation)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c KAZAN INSTITUTE OF BIOCHEMISTRY AND BIOPHYSICS   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDPLATE POTENTIAL; EXTRACELLULAR RECODING; FEMALE; INTRACELLULAR RECORDING; MOTOR NERVE; MOUSE; NERVE CELL PLASTICITY; NERVE FIBER GROWTH; NERVE REGENERATION; NERVE SPROUTING; NEUROMUSCULAR SYNAPSE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RECORDING; SYNAPTIC POTENTIAL; ADULT; BRAIN ELECTROPHYSIOLOGY; EPITROCHLEOANCONEUS MUSCLE; NEUROMUSCULAR TRANSMISSION; SKELETAL MUSCLE;

ANIMALS; BOTULINUM TOXIN TYPE A; DRUG ADMINISTRATION SCHEDULE; ELECTRIC STIMULATION; MICE; MOTOR NEURONS; MUSCLE, SKELETAL; NEUROMUSCULAR AGENTS; NEUROMUSCULAR JUNCTION; NEURONAL PLASTICITY; PARALYSIS;

EID: 47249120860     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2008.153569     Document Type: Article

References (67)

1. Alderson K, Holds JB & Anderson RL (1991). Botulinum-induced alteration of nerve-muscle interactions in the human orbicularis oculi following treatment for blepharospasm. Neurology 41, 1800-1805.
2. Angaut-Petit D, Molgo J, Comella JX, Faille L & Tabti N (1990). Terminal sprouting in mouse neuromuscular junctions poisoned with botulinum type A toxin: Morphological and electrophysiological features. Neuroscience 37, 799-808.
3. Arizono N, Koreto O, Iwai Y, Hidaka T & Takeoka O (1984). Morphometric analysis of human neuromuscular junction in different ages. Acta Pathol Japon 34, 1243-1249.
4. Barker D & Ip MC (1966). Sprouting and degeneration of mammalian motor axons in normal and de-afferentated skeletal muscle. Proc Roy Soc Lond B Biol Sci 163, 538-554.
5. Bradley SA, Lyons PR & Slater CR (1989). The epitrochleoanconeus muscles (ETA) of the mouse: A useful muscle for the study of motor innervation. J Physiol 415, 3 P.
6. Brigant JL & Mallart A (1982). Presynaptic currents in mouse motor endings. J Physiol 333, 619-636.
7. Brown MC, Holland RL & Ironton R (1980). Nodal and terminal sprouting from motor nerves in fast and slow muscles of the mouse. J Physiol 306, 493-510.
8. Cardasis CA & LaFontaine DM (1987). Aging rat neuromuscular junctions: A morphometric study of cholinesterase-stained whole mounts and ultrastructure. Muscle Nerve 10, 200-213.
9. Caroni P, Aigner L & Schneider C (1997). Intrinsic neuronal determinants locally regulate extrasynaptic and synaptic growth at the adult neuromuscular junction. J Cell Biol 136, 679-692.
10. Cashman NR, Covault J, Wollman RL & Sanes JR (1987). Neural cell adhesion molecule in normal, denervated, and myopathic human muscle. Ann Neurol 21, 481-489.
11. Cochilla AJ, Angleson JK & Betz WJ (1999). Monitoring secretory membrane with FM1-43 fluorescence. Annu Rev Neurosci 22, 1-10.
12. Day NC, Wood SJ, Ince PG, Volsen SG, Smith W, Slater CR & Shaw PJ (1997). Differential localization of voltage-dependent calcium channel alpha1 subunits at the human and rat neuromuscular junction. J Neurosci 17, 6226-6235.
13. del Castillo J & Katz B (1954). Quantal components of the end-plate potential. J Physiol 124, 560-573.
14. del Castillo J & Katz B (1956). Localization of active spots within the neuromuscular junction of the frog. J Physiol 132, 630-649.
15. de Paiva A, Meunier FA, Molgo J, Aoki KR & Dolly JO (1999). Functional repair of motor endplates after botulinum neurotoxin type A poisoning: Biphasic switch of synaptic activity between nerve sprouts and their parent terminals. Proc Natl Acad Sci U S A 96, 3200-3205.
16. Dolly JO & Aoki KR (2006). The structure and mode of action of different botulinum toxins. Eur J Neurol 13 (Suppl. 4), 1-9.
17. Dong M, Yeh F, Tepp WH, Dean C, Johnson E, Janz R & Chapman ER (2006). SV2 is the protein receptor for botulinum neurotoxin A. Science 312, 592-596.
18. Duchen LW (1970). Changes in motor innervation and cholinesterase localization induced by botulinum toxin in skeletal muscle of the mouse: differences between fast and slow muscles. J Neurol Neurosurg Psychiatry 33, 40-54.
19. Duchen LW, Excell BJ, Patel R & Smith B (1974). Changes in motor end-plates resulting from muscle fibre necrosis and regeneration. A light and electron microscopic study of the effects of the depolarizing fraction (cardiotoxin) of Dendroaspis jamesoni venom. J Neurol Sci 21, 391-417.
20. Foran PG, Davletov B & Meunier FA (2003). Getting muscles moving again after botulinum toxin: Novel therapeutic challenges. Trends Mol Med 9, 291-299.
21. Frey D, Schneider C, Xu L, Borg J, Spooren W & Caroni P (2000). Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases. J Neurosci 20, 2534-2542.
22. Goldman D, Brenner HR & Heinemann S (1988). Acetylcholine receptor α-, β-, γ-, and d-subunit mRNA levels are regulated by muscle activity. Neuron 1, 329-333.
23. Hall ZW (1973). Multiple forms of acetylcholinesterase and their distribution in endplate and non-endplate regions of rat diaphragm muscle. J Neurobiol 4, 343-361.
24. Hennig R & Lomo T (1985). Firing patterns of motor units in normal rats. Nature 314, 164-166.
25. Holds JB, Alderson K, Fogg SG & Anderson RL (1990). Motor nerve sprouting in human orbicularis muscle after botulinum A injection. Invest Ophthalmol Vis Sci 31, 964-967.
26. Jankovic J & Hallett M (1994). Therapy with Botulinum Toxin. Marcel Dekker, Inc., New York.
27. Juzans P, Comella JX, Molgo J, Faille L & Angaut-Petit D (1996a). Nerve terminal sprouting in botulinum type-A treated mouse levator auris longus muscle. Neuromuscul Disord 6, 177-185.
28. Juzans P, Molgo J, Faille L & Angaut-Petit D (1996b). Synaptotagmin II immunoreactivity in normal and botulinum type-A treated mouse motor nerve terminals. Pflugers Arch 431, R283-R284.
29. Katz B (1969). The Release of Neural Transmitter Substances. Liverpool University Press, Liverpool.
30. Katz B & Miledi R (1965). Propagation of electric activity in motor nerve terminals. Proc R Soc Lond B Biol Sci 161, 453-482.
31. Kim YI, Lomo T, Lupa MT & Thesleff S (1984). Miniature end-plate potentials in rat skeletal muscle poisoned with botulinum toxin. J Physiol 356, 587-599.
32. Klarsfeld A & Changeux JP (1985). Activity regulates the levels of acetylcholine receptor α-subunit mRNA in cultured chicken myotubes. Proc Natl Acad Sci U S A 82, 4558-4562.
33. Koltgen D, Ceballos-Baumann AO & Franke C (1994). Botulinum toxin converts muscle acetylcholine receptors from adult to embryonic type. Muscle Nerve 17, 779-784.
34. Liley AW (1956). An investigation of spontaneous activity at the neuromuscular junction of the rat. J Physiol 132, 650-666.
35. Lyons PR & Slater CR (1991). Structure and function of the neuromuscular junction in young adult mdx mice. J Neurocytol 20, 969-981.
36. Magrassi L, Purves D & Lichtman JW (1987). Fluorescent probes that stain living nerve terminals. J Neurosci 7, 1207-1214.
37. Mallart A & Brigant JL (1982). Electrical activity at motor nerve terminals of the mouse. J Physiol (Paris) 78, 407-411.
38. Martin AR (1955). A further study of the statistical composition of the end-plate potential. J Physiol 130, 114-122.
39. McLachlan EM & Martin AR (1981). Non-linear summation of end-plate potentials in the frog and mouse. J Physiol 311, 307-324.
40. Meunier FA, Lisk G, Sesardic D & Dolly JO (2003). Dynamics of motor nerve terminal remodeling unveiled using SNARE-cleaving botulinum toxins: The extent and duration are dictated by the sites of SNAP-25 truncation. Mol Cell Neurosci 22, 454-466.
41. Meunier FA, Schiavo G & Molgo J (2002). Botulinum neurotoxins: From paralysis to recovery of functional neuromuscular transmission. J Physiol (Paris) 96, 105-113.
42. Missias AC, Chu GC, Klocke BJ, Sanes JR & Merlie JP (1996). Maturation of the acetylcholine receptor in skeletal muscle: Regulation of the AChR gamma-to-epsilon switch. Dev Biol 179, 223-238.
43. Molgo J, Comella JX, Angaut-Petit D, Pecot-Dechavassine M, Tabti N, Faille L, Mallart A & Thesleff S (1990). Presynaptic actions of botulinal neurotoxins at vertebrate neuromuscular junctions. J Physiol (Paris) 84, 152-166.
44. Osborne SL, Latham CF, Wen PJ, Cavaignac S & Fanning Je (2007). The janus faces of botulinum neurotoxin: Sensational medicine and deadly biological weapon. J Neurosci Res 85, 1149-1158.
45. 2+ channel knockout mouse. Neuroscience 123, 75-85.
46. Pang K, Quinby J, Eyre J & Slater C (2002). The neuromuscular junction in cerebral palsy and its response to botulinum toxin-A. Dev Med Child Neurol 43 (Suppl. 90), 13.
47. Plomp JJ, van Kempen GT, De Baets MB, Graus YM, Kuks J & Be (1995). Acetylcholine release in myasthenia gravis: Regulation at single end-plate level. Ann Neurol 37, 627-636.
48. Plomp JJ, van Kempen GT & Molenaar PC (1992). Adaptation of quantal content to decreased postsynaptic sensitivity at single endplates in α-bungarotoxin-treated rats. J Physiol 458, 487-499.
49. Plomp JJ, van Kempen GT & Molenaar PC (1994). The upregulation of acetylcholine release at endplates of α-bungarotoxin-treated rats: its dependency on calcium. J Physiol 478, 125-136.
50. Sakaba T, Stein A, Jahn R & Neher E (2005). Distinct kinetic changes in neurotransmitter release after SNARE protein cleavage. Science 309, 491-494.
51. Santafe MM, Urbano FJ, Lanuza MA & Uchitel OD (2000). Multiple types of calcium channels mediate transmitter release during functional recovery of botulinum toxin type A-poisoned mouse motor nerve terminals. Neuroscience 95, 227-234.
52. Schiavo G, Matteoli M & Montecucco C (2000). Neurotoxins affecting neuroexocytosis. Physiol Rev 80, 717-766.
53. Sellin LC & Thesleff S (1981). Pre- and post-synaptic actions of botulinum toxin at the rat neuromuscular junction. J Physiol 317, 487-495.
54. Slater CR, Lyons PR, Walls TJ, Fawcett PR & Young C (1992). Structure and function of neuromuscular junctions in the vastus lateralis of man. A motor point biopsy study of two groups of patients. Brain 115, 451-478.
55. Slater CR & Rogozhin AA (2006). Do newly formed synaptic contacts account for functional recovery from botulinum toxin type A? Neurotoxicity Res 9, 221.
56. Thesleff S & Molgo J (1983). A new type of transmitter release at the neuromuscular junction. Neuroscience 9, 1-8.
57. Thesleff S, Molgo J & Lundh H (1983). Botulinum toxin and 4-aminoquinoline induce a similar abnormal type of spontaneous quantal transmitter release at the rat neuromuscular junction. Brain Res 264, 89-97.
58. Tonge DA (1974). Chronic effects of botulinum toxin on neuromuscular transmission and sensitivity to acetylcholine in slow and fast skeletal muscle of the mouse. J Physiol 241, 127-139.
59. Tsujimoto T, Umemiya M & Kuno M (1990). Terminal sprouting is not responsible for enhanced transmitter release at disused neuromuscular junctions of the rat. J Neurosci 10, 2059-2065.
60. Tuffery AR (1971). Growth and degeneration of motor end-plates in normal cat hind limb muscles. J Anat 110, 221-247.
61. 2+ channels. Proc Natl Acad Sci U S A 100, 3491-3496.
62. Walsh FS, Hobbs C, Wells DJ, Slater CR & Fazeli S (2000). Ectopic expression of NCAM in skeletal muscle of transgenic mice results in terminal sprouting at the neuromuscular junction and altered structure but not function. Mol Cell Neurosci 15, 244-261.
63. Windisch A, Gundersen K, Szabolcs MJ, Gruber H & Lomo T (1998). Fast to slow transformation of denervated and electrically stimulated rat muscle. J Physiol 510, 623-632.
64. Witzemann V, Brenner HR & Sakmann B (1991). Neural factors regulate AChR subunit mRNAs at rat neuromuscular synapses. J Cell Biol 114, 125-141.
65. Wood SJ & Slater CR (1997). The contribution of postsynaptic folds to the safety factor for neuromuscular transmission in rat fast- and slow-twitch muscles. J Physiol 500, 165-176.
66. Wood SJ & Slater CR (2001). Safety factor at the neuromuscular junction. Prog Neurobiol 64, 393-429.
67. Yee WC & Pestronk A (1987). Mechanisms of postsynaptic plasticity: remodeling of the junctional acetylcholine receptor cluster induced by motor nerve terminal outgrowth. J Neurosci 7, 2019-2024.